Ticker Details
Phathom Pharmaceuticals, Inc.
IPO Date:	October 21, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 3.56%
Avg Daily Range (30 D):	$0.37 | 3.23%
Avg Daily Range (90 D):	$0.41 | 3.09%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.94M
Avg Daily Volume (90 D):	.94M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	972
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$1.27M
Avg Institutional Trade (90 D):	$1.38M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.41M
Avg Closing Trade (30 D):	$1.59M
Avg Closing Trade (90 D):	$1.41M
Avg Closing Volume:	103.82K

News

Jan 8, 2026 @ 1:41 PM Stock Market Today: S&P 500, Dow Jones, Nasdaq 100... Source: Rishabh Mishra

Jan 8, 2026 @ 3:33 AM Phathom Pharmaceuticals Announces Pricing of $130 ... Source: Na

Oct 23, 2025 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals

Oct 20, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: Phathom Pharmaceuticals

Aug 20, 2025 @ 12:00 PM Phathom Pharmaceuticals Clarifies That There Is No... Source: Nick Benedetto

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.03	$-.27	$-3.03
Diluted EPS	$-3.03	$-.27	$-3.03
Revenue	$175.11M	$57.58M	$175.11M
Gross Profit	$152.51M	$49.94M	$152.51M
Net Income / Loss	$-221.25M	$-21.15M	$-221.25M
Operating Income / Loss	$-159.99M	$-5.93M	$-159.99M
Cost of Revenue	$22.6M	$7.65M	$22.6M
Net Cash Flow	$-167.29M	$-5.19M	$-167.29M
PE Ratio